Skip to main content
Emergency Alert
Request an Appointment
Pay a Bill
Clinical Trials
Careers
MyChart
UVA Health Children's
UVA Health
Find a Provider
Services
Locations
Patients & Visitors
Search
Search
Menu
Find a Provider
Services
Locations
Patients & Visitors
Search
Appointments
Billing
Clinical Trials
MyChart
Home
Clinical Trial Categories
Clinical Trials
In This Section
Clinical Trials
Principal Investigator
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma (AOST2031)
A Phase 2 Trial of Chemotherapy followed by Response Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor (ACNS2021)
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors (AGCT1531)
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG). (ACNS1821)
A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features (ACNS2031)
APhase 2 Study of Dabrafenib (NSC# 763760) with Trametinib (NSC# 763093) after Local Irradiation in Newly Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG) (IND #145355) (ACNS1723)
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (P3BEP)
Acute Leukemia
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831)
Brain Tumor
A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine (IND# 149832) for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors (ACCL2031)
Cerebral Palsy
Research study for children and adults ages 8 to 21 years old with cerebral palsy AND scoliosis
Healthy Subject Study
Hormone Study for Girls Ages 7 - 14
Hormone Studies
Hormone Study for Girls Ages 7 - 14
Adolescent Hormone Study for Girls Ages 7 - 18
Adolescent Hormone Study for Girls Ages 7 - 18
Hormone Study for Girls Ages 7 - 17
Hormone Study for Adolescent Girls Between the Ages of 10 - 17
Study for the use of spironolactone to regulate menses in girls with excess male hormone
Leukemia
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831)
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
Polycystic Ovarian Syndrome
Hormone Study for Girls Ages 7 - 14
Adolescent Hormone Study for Girls Ages 7 - 18
Adolescent Hormone Study for Girls Ages 7 - 18
Hormone Study for Girls Ages 7 - 17
Hormone Study for Adolescent Girls Between the Ages of 10 - 17
Study for the use of spironolactone to regulate menses in girls with excess male hormone
Scoliosis
Research study for children and adults ages 8 to 21 years old with cerebral palsy AND scoliosis
Research study for children and adults ages 10 to 21 years old with scoliosis